| Compound | Snap-8 |
|---|---|
| Category | Cosmetic octapeptide |
| Class | Neuro, Nootropic, and Cosmetic Peptides |
| Evidence tier | Minimal evidence |
| WADA status | Not individually listed; verify current status if subject to testing |
| Sold on this site | No — this is a reference database |
Overview
This entry covers Snap-8, a cosmetic octapeptide, graded "Minimal evidence" in this catalog's evidence system. There is little or no formal study of this compound. Claims rest on anecdote, theory, or very early-stage work; risk data are absent by definition.
A topical acetyl octapeptide marketed as a wrinkle-relaxation ingredient in cosmetics, loosely modeled on botulinum-toxin mechanism.
Mechanism of Action
Snap-8 is proposed to interfere with SNARE-complex-mediated acetylcholine release at the neuromuscular junction of facial expression muscles — a much weaker topical analog of botulinum action.
Research and Evidence
Evidence is limited to small industry-sponsored studies of wrinkle appearance; the cosmetic literature does not approach therapeutic evidence standards.
Safety and Side Effects
Topical cosmetic use is generally regarded as low-risk; injectable use is neither studied nor sensible.
Frequently Asked Questions
What is the evidence tier of Snap-8?
Snap-8 is graded "Minimal evidence" on this site. There is little or no formal study of this compound. Claims rest on anecdote, theory, or very early-stage work; risk data are absent by definition.
Is Snap-8 an approved medicine?
No. Minimal evidence means the compound has not reached universal regulatory approval; the tier description above explains exactly what level of evidence exists.
Where can I read the primary studies for Snap-8?
The references section at the end of this entry links the key primary sources — regulator labels, trial registrations, and peer-reviewed papers. Our "How to Read a Peptide Study" guide explains how to evaluate them.
References
- ClinicalTrials.gov — search for acetyl octapeptide studies. [source]
Evidence tier: Minimal evidence · Last reviewed: 2026-09-05 · Sources cited below.